BIO, Pew Weigh FDA's Revised Draft Guidance on Mixing, Diluting or Repackaging Biologics
By Michael Mezher -
Published 15 March 2017
The Biotechnology Innovation Organization (BIO) and the Pew Charitable Trusts are offering their input on the US Food and Drug Administration's (FDA) recently revised draft guidance on mixing, diluting or repackaging biologics.
Categories: News, US, FDA, Biologics and biotechnology, Manufacturing, Packaging
Tags: Mixing, Diluting, Repackaging, Compounding, Outsourcing Facilities, BIO, Pew